Zenas Biopharma (usa), Llc

This study is testing whether a new drug called obexelimab can prevent painful and damaging flare-ups in people with IgG4-related disease, a rare autoimmune condition. About 194 adults who are currently experiencing a flare-up will receive either the study drug or a placebo injec…

This study is testing whether a new injectable medication called obexelimab can help control relapsing multiple sclerosis. It will involve 93 people with MS who will receive either the drug or a placebo for 12 weeks, followed by a longer period where everyone gets the drug. Resea…